WEP Clinical LTD (WEP), a specialist services company that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available, has partnered with biopharmaceutical [...]
WEP Clinical (WEP) is pleased to announce a new partnership with Y-mAbs Therapeutics, Inc. (Y-mAbs), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. [...]
WEP Clinical LTD (WEP), a specialist services company that works with pharmaceutical companies to help patients and physicians gain access to medicines when no other treatment options are available, has partnered with TaiMed Biologics [...]
WEP Clinical (WEP) is pleased to announce our partnership with Pharming Group N.V. ("Pharming" EURONEXT Amsterdam: PHARM/Nasdaq: PHAR), a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and [...]
WEP Clinical Inc. (WEP) is pleased to announce that it has partnered with Sellas Life Sciences Group, Inc. (“Sellas”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for various cancer [...]
WEP Clinical (WEP), a specialist services company that works with sponsors to help patients and physicians gain early access to medicines when no other treatment options are available, has appointed Karl Challender as the [...]
WEP Clinical (WEP) today announced a partnership with Horizon Therapeutics plc (Horizon) to make a Named Patient Use (NPU) Program available for UPLIZNA. The UPLIZNA NPU Program is for adult patients who are AQP4-IgG+ [...]
WEP Group Holdings Limited (WEP Clinical) is pleased to announce the closure of an investment in the company made by The Jordan Company, L.P. (TJC), a middle-market private equity firm. Under the terms of [...]
WEP Clinical LTD (WEP), a specialist services company that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available, has partnered with biopharmaceutical [...]
WEP Clinical Ltd (WEP), a specialist services company that works with drug developers to help patients and physicians gain early access to medicines, is pleased to announce the execution of a Master Services Agreement [...]